Welcome
Support Centre
02 September 2010 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Randomised controlled trial to compare the functional outcome of the standard NexGen Legacy knee replacement to that of the NexGen Legacy Flex knee replacement which is designed to allow a greater range of flexion in the knee
ISRCTN ISRCTN71676516
ClinicalTrials.gov identifier
Public title Randomised controlled trial to compare the functional outcome of the standard NexGen Legacy knee replacement to that of the NexGen Legacy Flex knee replacement which is designed to allow a greater range of flexion in the knee
Scientific title
Acronym N/A
Serial number at source Z0002
Study hypothesis Does the use of the NexGen Legacy Flex knee replacement produce significantly better outcomes than those obtained with the standard NexGen Legacy knee replacement ?
Ethics approval The study was approved by the Lothian Research Ethics Committee on 17/2/2004 (ref: LREC2003/1/36).
Study design Prospective, double blind, randomised controlled trial.
Countries of recruitment United Kingdom
Disease/condition/study domain Total knee replacement surgery in patients with osteoarthritis
Participants - inclusion criteria Patients with knee osteoarthritis who are on the waiting list to undergo unilateral total knee arthroplasty at the New Royal Infirmary in Edinburgh and who can passively flex their knee 90 degrees or more.
Participants - exclusion criteria 1. Inflammatory polyarthritis
2. Disorders of the feet, hips or spine causing abnormal gait or significant pain
3. Dementia
4. Severe visual impairment
5. Neurological conditions affecting movement
6. Inability to give informed consent
Anticipated start date 01/03/2004
Anticipated end date 31/12/2006
Status of trial Completed
Patient information material
Target number of participants 80, 40 in each group
Interventions Standard NexGen Legacy knee replacement versus the NexGen Legacy Flex knee replacement
Primary outcome measure(s) Functional range of movement of the knee using flexible electrogoniometry
Secondary outcome measure(s) 1. Passive range of motion
2. Pain
3. Knee extensor and flexor strength
4. Walking speed
5. Woman on the Move Against Cancer (WOMAC)
6. Knee Society Score
7. Daily Physical Activity
8. Quality of Life
Sources of funding Zimmer UK Ltd (ref: Z0002)
Trial website
Publications Results in http://www.ncbi.nlm.nih.gov/pubmed/18160497
Contact name Dr  Marietta  van der Linden
  Address School of Health Sciences
Queen Margaret University College
Duke Street
  City/town Edinburgh
  Zip/Postcode EH6 8HF
  Country United Kingdom
  Tel +44 (0)131 3173820
  Email mvanderlinden@qmuc.ac.uk
Sponsor Queen Margaret University College (UK)
  Address Clerwood Terrace
  City/town Edinburgh
  Zip/Postcode EH12 8TS
  Country United Kingdom
  Tel +44 (0)131 3173000
  Email whardcastle@qmuc.ac.uk
  Sponsor website: http://www.qmuc.ac.uk
Date applied 13/10/2006
Last edited 27/06/2008
Date ISRCTN assigned 04/12/2006
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2010 ISRCTN unless otherwise stated.


BioMed Central